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Short title: Kinetic protein-based isopeptidase assay for TG2 
 
HIGHLIGHTS 
 
Novel protein substrate for isopeptidase activity assay of TG2 
Confirmation of specific isopeptidase cleavage of new substrate  
Development of a fluorescence polarisation based kinetic assay  
Effect of regulatory ligands, mutations and inhibitors  
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ABSTRACT 
 
Transglutaminase 2 (TG2) is a ubiquitously expressed multifunctional protein with Ca2+-
dependent transamidase activity forming protease resistant Nε-(γ-glutamyl)lysine crosslinks 
between proteins. It can also function as an isopeptidase cleaving the previously formed 
crosslinks. The biological significance of this activity has not been revealed yet mainly because 
of the lack of protein based method for its characterization. Here we report development of a 
novel kinetic method for measuring isopeptidase activity of human TG2 by monitoring decrease 
in the fluorescence polarisation of a protein substrate previously formed by crosslinking 
fluorescently labelled glutamine donor FLpepT26 to S100A4 at a specific lysine residue. The 
developed method could be applied to test mutant enzymes and compounds which influence 
isopeptidase activity of TG2.  
 
 
Keywords: transglutaminase 2, S100A4, isopeptidase activity, fluorescence anisotropy
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INTRODUCTION 
 
Transglutaminase 2 (TG2, EC 2.3.2.13) is a ubiquitously expressed, multifunctional member of 
transglutaminases having several catalytic activities and involved in protein-protein interactions 
both intra- and extracellularly [1]. It has been implicated in a variety of biological processes, 
including cellular differentiation, apoptosis, angiogenesis, extracellular matrix organisation and 
linked to immunological, fibrotic, cancer and neurodegenerative disease phenotypes [2,3]. TG2 
has various catalytic activities in addition to the well characterized transamidation that is 
formation of covalent bonds between protein-bound glutamine and lysine residues or primary 
amines; it can also work as a GTPase, a protein disulphide isomerase and a protein kinase under 
specific conditions [3]. The Ca2+-dependent transglutaminase activity can also mediate 
deamidation of glutamine residues and hydrolysis of the previously formed Nε-(γ-glutamyl)lysine 
as well as γ-glutamylamine derivatives (isopeptidase activity); these reaction mechanisms are 
reviewed in [4]. The transamidase activity forms a proteinase resistant isopeptide bond which has 
structural, functional and even industrial implications, for example in clot stabilization by the 
transglutaminase Factor XIIIa [1], formation of cornified envelopes by transglutaminases in the 
skin [5], cross-linking of extracellular matrix in kidney fibrosis and food, textile and leather 
processing to improve flavour, appearance and texture [2,6,7]. 
Hitherto, only a few reports have been published on the existence and characterization of the 
isopeptidase activity of TG2. The removal of the previously incorporated monoamines 
(deaminylation) [8-11] and the isopeptide cleavage between short peptides [12] were 
demonstrated measuring fluorescence intensity change or using capillary electrophoresis. On a 
protein level only Factor XIIIa catalysed isopeptidase activity was detected what can reverse the 
incorporation of α2-plasmin inhibitor into fibrin clots potentially regulating the fibrinolytic 
processes [13,14]. This raised the possibility that isopeptidase activity of TG2 could also play 
important roles in regulation of biological processes. However, in the lack of proper and easily 
accessible assay the full biological and pathological significance of this activity cannot be 
revealed. 
A real-time fluorescence polarization assay has been published [15] to measure transamidase 
activity of TG2 during crosslinking a fluorescently labelled TG2 specific dodecapeptide 
(FLpepT26) into bovine serum albumin (BSA) resulting in higher anisotropy of the 
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enzymatically crosslinked product. We hypothesized that in case of a proper lysine donor 
substrate after the forward reaction the cleavage of isopeptide bond by TG2 also leads to 
anisotropy change which could be monitored using the same biophysical feature utilized in 
proteinase and deubiquitinating assays [16,17]. 
Here we report the development of a kinetic fluorescent polarization based assay to follow 
isopeptidase activity of TG2 on a novel crosslinked protein-peptide substrate. By enzymatic 
crosslinking of the fluorescently labelled FLpepT26 dodecapeptide and S100A4, a recently 
characterized specific amine donor of TG2 [18], the purified product was subsequently used as a 
substrate to demonstrate the cleavage of the isopeptide bond and follow this activity by 
measuring fluorescence polarization in real time.  
 
MATERIALS AND METHODS 
 
Materials 
All materials were purchased from Sigma (St Louis, MO, USA) unless otherwise indicated. The 
FLpepT26 peptide was obtained as published in [18]. ZDON was sold by Zedira (Darmstadt, 
Germany). 
 
Expression and purification of proteins 
The Val224 containing recombinant human TG2 (Uniprot code: P21980) and its mutants were 
expressed in N-terminally (His)6-tagged form (pET-30 Ek/LIC-TG2; Mw: 82,745 Da) and 
purified by Ni-NTA affinity chromatography as described previously [11]. 
N-terminal GST-tagged S100A4 (pETARA-S100A4; Uniprot code: P26447; Mw: 39,559 Da) 
was expressed in Rosetta 2 (Novagen, Darmstadt, Germany). The overnight culture was 
inoculated in 1:20 ratio into LB medium containing 50 µg/mL ampicillin and 34 µg/mL 
chloramphenicol and was grown at 25°C until the optical density reached 0.6–0.8 at 600 nm. The 
expression was induced with 0.1 mM IPTG at 18°C overnight. Cells were harvested and pellets 
were dissolved in Buffer A (20 mM Tris-HCl pH 7.2, 150 mM NaCl, 1 mM EDTA, 1 mM DTT) 
containing 1% Triton X-100, 10% glycerol, 1 mM PMSF and protease inhibitor cocktail. After 
sonication the supernatant was separated by centrifugation at 20000g, 4°C, 25 min and loaded 
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onto Glutathione Sepharose 4B resin (GE Healthcare, UK). After extensive washing with Buffer 
A the S100A4(GST) protein was eluted using 10 mM reduced glutathione in Tris-HCl pH 8.0 and 
dialyzed overnight in buffer A. Protein concentration was determined by Bradford method (Bio-
Rad Protein Assay, Bio-Rad, München, Germany). 
 
Large scale production of the crosslinked FLpepT26-S100A4(GST) 
The mixture of 5 µM FLpepT26, 12.8 µM S100A4(GST) and 5 nM TG2 was incubated for 1 
hour in the presence of 5 mM Ca2+ in the reaction buffer 20 mM Tris-HCl pH 7.5 containing 150 
mM NaCl, 5 mM DTT and 0.01% Tween 20. The reaction was stopped by the addition of 10 mM 
EDTA (final concentration) to prevent unwanted modification of the crosslinked molecules 
during their separation. FLpepT26-S100A4(GST) with unmodified S100A4(GST) were purified 
from the free, unbound FLpepT26 peptide by centrifugal concentrator filter (Amicon ultra, 10 
kDa, Millipore, Billerica, MA, USA). Then the buffer was replaced by 20 mM MOPS buffer, pH 
6.8 containing 0.5 mM EDTA, 150 mM NaCl, 5 mM DTT, 0.01% Tween 20 because 
isopeptidase activity prefers slightly acidic pH [19]. Due to co-purification of FLpepT26-
S100A4(GST) and S100A4(GST) their ratio was calculated based on the total protein 
concentration (determined by Bio-Rad Protein Assay) and its fluorescein content (absorption at 
493 nm) using 79600 M-1 cm-1 as molar extinction coefficient for fluorescein. In optimized 
conditions the FLpepT26-S100A4(GST) content was approximately 15% as an average in the 
reaction product meaning that 5 µg purified mixture of FLpepT26-S100A4(GST) and 
S100A4(GST) corresponds to 0.5 µM FLpepT26-S100A4(GST) in 35 µl of the isopeptidase 
assay. 
 
Preparation of samples for SDS-PAGE analysis 
The reaction was stopped by adding 6x denaturation buffer (375 mM Tris-HCl, pH 6.8, 600 mM 
DTT, 12% (m/v) SDS, 60% (v/v) glycerol, 0.06% (m/v) bromophenol blue) and the samples were 
boiled for 10 min. SDS-PAGE was performed using 15% Tris-Glycine gel. The fluorescence was 
detected immediately by an UV gel documentation system (Protein Simple, AlphaImager, HP 
system). 
 
Mass spectrometric analysis of the peptide after isopeptide cleavage 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
Real-time kinetic method to monitor isopeptidase activity of transglutaminase 2 on protein 
substrate 
6 
 
Electrospray ionization mass spectrometric measurements were carried out on a Bruker Daltonics 
Esquire 3000plus (Bremen, Germany) ion trap mass spectrometer using on-line HPLC coupling. 
HPLC separation was performed on a Jasco PU-2085Plus HPLC system using a Supelco Ascentis 
C18 column (2.1 x 150 mm, 3 µm). Linear gradient elution (0 min 2% B; 3 min 2% B; 27 min 
60% B) with eluent A (0.1% HCOOH in water) and eluent B (0.1% HCOOH in acetonitrile-water 
(80:20, V/V)) was used at a flow rate of 0.2 ml/min at ambient temperature. The HPLC was 
directly coupled to the mass spectrometer. Collision induced dissociation (CID) experiments 
were used for peptide sequencing. 
 
Kinetic isopeptidase activity measurement  
In 35 µl reaction volume on 384-well Untreated Polystyrene Black Microplates (Nunc, Thermo 
Scientific, Denmark; catalog# 262260) 0.5 µM of the FLpepT26-S100A4(GST) crosslinked 
substrate were tested in 20 mM MOPS pH 6.8 reaction buffer containing, 150 mM NaCl, 6 mM 
glycine methyl ester, 5 mM DTT, 0.1% Tween 20 and various concentration of TG2. The 
reaction was started by the addition of 5 mM CaCl2 (5 mM EDTA was used as negative control) 
and performed at 37°C, measuring the change in fluorescence polarization (FP) value by Synergy 
H1 microplate reader (GreenFP filter cube, Ex: 485 nm, Em: 528 nm; BioTek, Winooski, VT, 
USA). The reaction rates were calculated from the initial slopes of the kinetic curves in terms of 
anisotropy per minutes. 
 
Data analysis 
Data analysis, curve fitting, kinetic calculations were performed by GraphPad Prism 5 software 
(Graphpad Software Inc. La Jolla, CA, USA) using the appropriate incorporated equations and 
tools mentioned where it is appropriate. In case of Ca2+-dependence experiments the free 
calcium-ion concentrations were calculated using the online version of MaxChelator 
(WEBMAXC STANDARD; http://www.stanford.edu/~cpatton/maxc.html) due to the EDTA 
content of the substrate. 
 
RESULTS AND DISCUSSION 
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Design and production of the potential transglutaminase isopeptidase substrate for 
anisotropy assay 
To develop a peptide-protein based isopeptidase assay, the first step was to select proper substrate 
components for the production of a substance that contains only one Nε-(γ-glutamyl)lysine 
isopeptide bond and the substrates have significant difference in their size to provide sufficient 
signal for the detection of anisotropy change. In previous publications fluorescein labelled 
FLpepT26 peptide was an effective TG2 specific amine acceptor substrate [15] that could be 
incorporated into the amine donor BSA and recently into S100A4 monitored by fluorescence 
polarisation assay [18]. Both FLpepT26-BSA and FLpepT26-S100A4 as Nε-(γ-glutamyl)lysine 
cross-linked products were considered as substrates for isopeptidase activity measurements. 
However, BSA contains several surface exposed Lys residues compared to S100A4 which has 
only one TG2 reactive Lys residue (Lys100), and unlike BSA, S100A4 does not contain 
transglutaminase reactive glutamine residues [18] making S100A4 an ideal candidate to serve as 
a substrate in an isopeptidase reaction. To compensate the size difference between S100A4 (11.5 
kDa) and BSA and to get higher anisotropy change and better fluorescence polarization signal in 
the designed assay, S100A4 was expressed with GST-tag. GST alone did not show explicit 
activity neither as an amine donor (in fluorescence anisotropy assay with FLpepT26 peptide, Fig. 
S1A) nor as an amine acceptor (in dansyl-cadaverine incorporation assay, Fig. S1B). In the 
transamidase reaction the Km values for S100A4(GST) and BSA were comparable with earlier 
observations [15,18], while Vmax was approximately 10 times higher in case of S100A4(GST) as 
amine donor (Fig. S1C) suggesting that S100A4(GST) could be a very potent Lys donor to 
produce an isopeptidase protein substrate with a single isopeptide bond. 
The crosslinking reaction was carried out in large scale as described in Materials and Methods to 
produce the FLpepT26-S100A4(GST) containing the Nε-(γ-glutamyl)lysine bond. The reaction 
was stopped by the addition of 10 mM EDTA (final concentration) to prevent unwanted further 
modification of the crosslinked molecules during their separation from free FLpepT26 peptide 
and the buffer was replaced to MOPS buffer, pH 6.8 for optimal isopeptidase activity [19] 
(Scheme on Fig. 1A). 
The efficiency of the separation was checked on SDS-PAGE confirming the presence of the 
crosslinked, fluorescently labelled FLpepT26-S100A4(GST) molecule at ~42 kDa molecular 
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weight in the gel (Fig. 1B) and disappearance of the FLpepT26 peptide which has 1885 Da 
molecular weight but generally appears in the gel as a 10 kDa diffuse band. 
 
Validation of the potential FLpepT26-S100A4(GST) as isopeptidase substrate for TG2 
The prepared product was tested to check whether it can be used as a substrate for TG2 
isopeptidase activity measurement. The result of the cleavage of the isopeptide bond could be 
visualized by SDS-PAGE (Fig. 1B). The acceptance of FLpepT26-S100A4(GST) by TG2 as 
isopeptidase substrate can be easily followed as the amount of the substrate decreases while 
increasing amount of the released fluorescein-conjugated peptide appears during the enzymatic 
reaction. 
To further confirm that isopeptidase activity occurred, the product of the isopeptidase reaction 
was applied to a Jupiter 300 C5 RP-HPLC column (Phenomenex) and the peak corresponding to 
the deamidated FLpepT26 was further analysed by HPLC-ESI-MS/MS. The results showed that 
the released peptide was a single compound with a molecular mass of 1884.9 Da with slightly 
higher retention time compared to FLpepT26 (1886.1 Da) (Fig. S2 and S3). Both peptides were 
subjected to collision induced dissociation to confirm the location of the mass difference (Fig. 
S4). MS/MS sequencing of the triply protonated parent ions (m/z 629.3 and 629.7) resulted in a 
complete set of mainly b and y type fragment ions (fragmentation pathway is presented in Fig. 
S4). The identified peptide fragments correlate with the sequence of FLpepT26 confirming the 
reliability of the analysis. Based on the mass differences of the N-terminal peptide fragments, the 
Gln to Glu transformation in the released peptide was unambiguously confirmed (Table S1). 
 
Testing FLpepT26-S100A4(GST) as a suitable substrate for kinetic measurement of 
isopeptidase assay 
After demonstration of effective hydrolysis of FLpepT26-S100A4 by TG2 we tested its 
correlation with decreased anisotropy. Since the crosslinking could be followed by the increase of 
anisotropy [15,18], it was expected that anisotropy should be decreased over time during the 
isopeptidase reaction. Indeed, anisotropy signal followed an exponential decay; and using linear 
regression based on the first phase (9-10 minutes) of the decrease, reaction rates were calculated 
in the range of 10-600 nM TG2 concentration (Fig. 1C). At lower TG2 concentration the decrease 
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of anisotropy was less significant and the higher noise (deviances of the single measured values 
from the fitted curve on the values) prevented the determination of isopeptide bond cleavage. The 
remaining isopeptidase activity of the enzyme used for isopeptide substrate generation was 
checked by the comparison of the reaction rates in the presence of 5 mM calcium or EDTA 
without adding any further TG2, but there was no significant difference between the slope of the 
curves (Fig. 1C). At 5 µg substrate (which corresponds to 0.5 µM concentration) we could detect 
isopeptidase activity at 10 nM TG2 concentration, while the reaction rate was linearly dependent 
on TG2 concentration in the 10-300 nM range (Fig. 1D). The commercially available, not protein 
based kinetic isopeptidase activity assays, which measure deaminylation of small non-specific 
peptides by TG2 at 50 µM substrate concentration (Zedira assay), has similar sensitivity with a 
detection limit of approximately 13 nM TG2 [20]. 
Next, we measured the effect of increasing FLpepT26-S100A4(GST) substrate concentration on 
the reaction rate at fixed TG2 level (0.3 µM TG2, 5 mM Ca2+) and we have observed saturation 
kinetics on which curve was fitted based on the Michaelis-Menten equation (Fig. 2A; coefficient 
of determination: R2=0.9871). Here, the activity attained a plateau phase and an enzymatic 
dissociation constant (Km) was calculated to be 53.9±4.4 nM for FLpepT26-S100A4(GST) and 
Vmax to be 57.9±0.9 mr/min/µM TG2 using Graphpad Prism 5. This Km value is extremely low 
compared to published values for human TG2. We measured 13.3 µM and 54.3 µM Km values 
using Zedira assay with A101 and A102 isopeptidase substrates (deaminylation activity), 
respectively, in which test the substrates are peptides containing an incorporated unspecific amine 
(quencher labelled cadaverine) [11]. In other transglutaminase assays when deamidation was 
detected by kinetic spectrophotometric assay using Cbz-Gln-Gly as substrate, the Km value was 
in the mM range [21]. In case of the cleavage of isopeptide bond between cross-linked peptides, 
the Km values were also in micromolar range [12]. This demonstrates that our newly developed 
method based on the novel protein substrate can serve as a highly sensitive and specific reaction 
to detect and measure TG2 isopeptidase activity. Furthermore, the high reactivity of TG2 with 
isopeptide bonds shown here suggests that its isopeptidase activity may have physiological 
relevance not described yet. 
Considering that the added substrate in the assay is a mixture of the isopeptide bond containing 
FLpepT26-S100A4(GST) and free S100A4(GST), a significant amount of free S100A4(GST) is 
present raising the possibility that S100A4(GST) may have influence on the isopeptidase 
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reaction. To address this concern, the effect of S100A4(GST) on the isopeptidase activity was 
analysed using the above mentioned Zedira assay which contains small peptide substrate and our 
protein substrate based assays (Fig. S5A and B, respectively). The increasing S100A4(GST) 
concentration results in dose dependent increase of isopeptidase activity of TG2 in the Zedira 
assay; this may be explained by the reported interaction of TG2 and S100A4 [18] leading to the 
potential stabilization of the active conformation of the enzyme because in previous study amine 
donor substrates did not influence isopeptidase activity [11]. On the other hand, in the protein-
based assay, the increasing concentration of S100A4(GST) did not lead to change of the 
isopeptidase activity, probably due to the relatively high ratio of S100A4(GST) concentration in 
the substrate which already could be in saturation without addition of extra S100A4(GST). To 
further increase the efficiency of the developed assay the peptide incorporation ratio should be 
further improved to eliminate this potential limitation factor of the method for broad applications. 
The effect of glycine methyl ester, which was present in the assay solutions, was also checked on 
the protein-based isopeptidase reaction because it was proposed to facilitate the regeneration of 
the enzyme from the thiol intermediate state during the isopeptidase reaction (aminolysis) [20]. 
However, fluorescence polarization was comparable both in the presence or absence of glycine 
methyl ester (data not shown) in concordance with our earlier observations [11] and the MS 
analysis has not identified transamidated peptide product in the applied assay conditions 
suggesting that transamidation does not have significant rate in TG2 catalysed reaction (Fig. S4) 
[9]. 
To further characterize the kinetics of the protein-peptide based isopeptidase reaction, Ca2+-
dependency was also tested since TG2 undergoes a large conformational change during its 
activation by Ca2+ [22] that could influence substrate accessibility to the active site (Fig. 2B). 
Generally, the crosslinking and the deaminylation activity of wild type TG2 reaches the 
maximum reaction rate in the presence of approximately 1.5 mM Ca2+ concentration [23]. 
However, in case of FLpepT26-S100A4(GST) cleavage, 4-5 mM Ca2+ concentration was needed 
to saturate the reaction rate (WT EC50 0.96±0.17 mM, calculated by fitting a dose-response curve 
hypothesising standard slope) suggesting that isopeptidase activity may have more important role 
in the extracellular matrix where Ca2+ concentration is higher than in the cytosol. 
Intracellularly, TG2 activity is regulated reciprocally by Ca2+ and nucleotides [3]. The inhibitory 
effect of GTPγS, a stable GTP compound, was also tested on isopeptidase activity of TG2 (Fig. 
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2D). GTPγS had similar inhibitory effect on isopeptidase activity of TG2 in the protein-based as 
in the Zedira assay (with A102 substrate) [11]. 
To see the importance of the substrate quality, crosslinked BSA-FLpepT26 was also produced 
and tested in the isopeptidase assay, but no reaction could be detected by either monitoring 
polarisation change or by SDS-PAGE analysis (data not shown). This provides further evidence 
for the importance of the applied protein substrate containing the isopeptide bond to detect 
specific isopeptide cleavage. The active lysine S100A4 residue, involved in crosslinking, is 
localized in the C-terminal tail of S100A4 that could be easily accessible for the active site of 
TG2. 
 
Potential applications of the newly developed kinetic isopeptidase assay 
There is an increasing interest from the pharmacological industry to regulate transglutaminase 
activity by inhibitors, particularly in neurodegenerative diseases, kidney or pulmonary fibrosis 
and to prevent thrombosis [3]. However, the effects of newly developed inhibitors were always 
tested on the crosslinking activity of TG2 and there has been no comparison of their effect on 
isopeptidase activity of TG2, particularly in a kinetic, protein substrate assay that has not existed 
so far. A commercially available, cell permeable, irreversible active site directed inhibitor of 
TG2, the ZDON (Zedira, [24]) was tested in our newly developed method (Fig. 2C). 
Approximately 0.3 µM ZDON was enough for complete inhibition of the isopeptidase activity 
which is in a good correlation with the expected value in case of an irreversible inhibitor in the 
presence of 0.3 µM TG2 although the apparent IC50 value was 30.7 nM (calculated by fitting a 
dose-response curve hypothesising standard slope) which is lower than a reported one in an in 
vitro transamidation assay [24].  
Enzyme assays are useful to characterise the effect of mutations on activity. In our recent study 
two special mutants have been produced [11]. One which is deficient in transamidase activity but 
has higher isopeptidase activity compared to the wild type (isopeptidase mutant W332F), and 
another with opposite characteristics (transamidase mutant W278F). Interestingly, in the protein-
based assay both mutants demonstrated lower activity than wild type TG2 (Fig. 2E; 46.6% and 
78.6%, respectively). Moreover, the W332F mutant showed lower while the W278F mutant 
higher activity compared to the Zedira deaminylation assay [11]. The larger size of the substrate 
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may mask the earlier observed differential effect of these mutations [11] suggesting that steric 
features have a strong control on the TG2 isopeptidase activity.  
For more detailed study of isopeptidase activity and its biological significance, the replacement 
of the substrate components with other TG2 specific substrates could provide further mechanistic 
details about the isopeptidase reaction. Results of such studies can lead to pharmacological 
approaches to accelerate the removal of pathologically accumulated, Nε-(γ-glutamyl)lysine cross-
linked proteins from fibrotic tissues or in case of neurodegenerative disorders. These bonds 
otherwise are catabolized slowly requiring degradation by proteases to yield γ-glutamyl-ε-lysine 
isodipeptide that is released into the circulation to be cleaved by γ-glutamilamine 
cyclotransferase in the intestine and kidney [25,26]. 
 
 
CONCLUSIONS 
 
We have developed a kinetic method to follow isopeptidase activity of TG2 in real time using a 
cross-linked protein substrate in the presence and absence of different effectors/inhibitors. 
Reversible covalent modifications of proteins have crucial regulatory functions in cells and 
tissues like those mediated by ubiquitin ligases and deubiquitinases or kinases and phosphatases. 
Unlike phosphorylation and ubiquitination there are no enzymes in nature to reverse 
transglutaminase mediated protein cross-linking. Instead, transglutaminases themselves, such as 
TG2 possess hydrolytic activity to cleave the Nε-(γ-glutamyl)lysine bonds which they produce. 
The biological and regulatory significance of this reaction as well as the potential use of the 
isopeptidase activity of transglutaminases in pathologic conditions require further investigations. 
We believe that the presented assay can serve as a useful tool for those kind of studies.  
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FIGURES: 
 
Fig 1. Design and implementation of the fluorescence anisotropy assay that monitors isopeptidase 
activity of TG2. (A) Work scheme: FLpepT26 peptide and S100A4(GST) are crosslinked by TG2 
and after separation of the free peptide the isopeptide containing FLpepT26-S100A4(GST) serves 
as isopeptidase assay substrate. (B) Visualization of the isopeptide cleavage on FLpepT26-
S100A4(GST); the monitored kinetic reactions were performed for 90 mins at 37°C then 
products were separated by 15% SDS-PAGE and detected in an UV gel documentation system. 
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Representative gel image of FLpepT26 peptide (11.3 ng peptide, lane 1), separated FLpepT26-
S100A4(GST) isopeptidase substrate (8.6 µg protein, lane 2), product of isopeptidase reactions 
on the substrate in the presence of 300 nM TG2 and 5 mM EDTA (lane 3) or in the presence of 5 
mM Ca2+ and different TG2 concentrations (0.06, 0.3, 0.6, 1.2 µM, lane 4-7, respectively; 2.8 µg 
substrate protein). (C) Real-time monitoring of the isopeptide cleavage by measuring the 
anisotropy change using 5 µg substrate protein mixture in 35 µl reaction mix (0.5 µM FLpepT26-
S100A4(GST)), 5 mM Ca2+ or EDTA and various concentrations of TG2. (D) The rate of 
anisotropy change shows linear correlation between 10-300 nM TG2 concentration. The inset 
shows the linear range analysed by GraphPad Prism 5 using Pearson correlation analysis 
(P<0.0001, r=0.990). Data are presented as means with ±SD from three separate experiments 
done in triplicate. 
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Fig 2 Characterisation of the newly developed protein based isopeptidase assay. Determination of 
the Michaelis constant (A), the Ca2+-dependence (B), the inhibitory effect of ZDON (C) and 
GTPγS (D). ZDON inhibitor was tested after 5 minutes preincubation in the presence of 5 mM 
Ca2+, 0.3 µM TG2 and 5 µg of substrate while in the case of GTPγS-dependence the Ca2+ 
concentration was 2 mM. Mutants (E) were also tested in the presence of 5 mM Ca2+ and at 300 
nM TG2 concentration. In all negative control experiments 5 mM EDTA was present instead of 
Ca2+. Data are presented as means with ±SD from two separate experiments done in triplicate.  
 
 
